Jennifer Chien Rhythm Pharmaceuticals, Inc. (RYTM) insider trading activity

Jennifer Chien is EVP, Head of North America of RHYTHM PHARMACEUTICALS, INC.. Currently has a direct ownership of 972 shares of RYTM, which is worth approximately $54,956. The most recent transaction as insider was on Nov 11, 2024, when has been sold 66,861 shares (Common Stock) at a price of $67.15 per share, resulting in proceeds of $4,489,716. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 972

85.81% 3M change

Infinity% 12M change

Total Value Held $54,956

Jennifer Chien Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 11 2024	SELL Open market or private sale	$4,489,716 $67.15 p/Share	66,861 Reduced 98.57%	972 Common Stock
Nov 11 2024	BUY Exercise of conversion of derivative security	$1,254,988 $20.58 p/Share	60,981 Added 47.34%	67,833 Common Stock
Mar 20 2024	SELL Open market or private sale	$707,153 $38.78 p/Share	18,235 Reduced 72.69%	6,852 Common Stock
Mar 19 2024	SELL Open market or private sale	$608,498 $39.22 p/Share	15,515 Reduced 38.21%	25,087 Common Stock
Feb 16 2024	BUY Grant, award, or other acquisition	-	33,750 Added 45.39%	40,602 Common Stock
Feb 13 2024	SELL Open market or private sale	$30,645 $49.83 p/Share	615 Reduced 8.24%	6,852 Common Stock
Feb 12 2024	SELL Open market or private sale	$52,561 $51.38 p/Share	1,023 Reduced 12.05%	7,467 Common Stock
Feb 11 2024	BUY Exercise of conversion of derivative security	-	2,031 Added 19.3%	8,490 Common Stock
Feb 09 2024	BUY Exercise of conversion of derivative security	-	3,438 Added 34.74%	6,459 Common Stock
Feb 01 2024	SELL Open market or private sale	$67,229 $45.06 p/Share	1,492 Reduced 33.06%	3,021 Common Stock
Feb 01 2024	BUY Exercise of conversion of derivative security	-	4,513 Added 50.0%	4,513 Common Stock
Nov 14 2023	SELL Open market or private sale	$437,800 $32.01 p/Share	13,677 Reduced 100.0%	0 Common Stock
Nov 14 2023	BUY Exercise of conversion of derivative security	$81,804 $6.8 p/Share	12,030 Added 46.8%	13,677 Common Stock
Nov 09 2023	SELL Open market or private sale	$95,198 $27.69 p/Share	3,438 Reduced 67.61%	1,647 Common Stock
Nov 09 2023	BUY Exercise of conversion of derivative security	$23,378 $6.8 p/Share	3,438 Added 40.34%	5,085 Common Stock
Nov 08 2023	SELL Open market or private sale	$165,476 $28.97 p/Share	5,712 Reduced 77.62%	1,647 Common Stock
Nov 08 2023	BUY Exercise of conversion of derivative security	$38,841 $6.8 p/Share	5,712 Added 43.7%	7,359 Common Stock
Nov 03 2023	SELL Open market or private sale	$2,240 $28.0 p/Share	80 Reduced 4.63%	1,647 Common Stock
Nov 03 2023	BUY Exercise of conversion of derivative security	$544 $6.8 p/Share	80 Added 4.43%	1,727 Common Stock
Sep 05 2023	SELL Open market or private sale	$172,956 $28.05 p/Share	6,166 Reduced 78.92%	1,647 Common Stock
Sep 05 2023	BUY Exercise of conversion of derivative security	$30,729 $6.8 p/Share	4,519 Added 36.64%	7,813 Common Stock
Aug 09 2023	SELL Open market or private sale	$42,365 $24.66 p/Share	1,718 Reduced 34.28%	3,294 Common Stock
Aug 09 2023	BUY Exercise of conversion of derivative security	$11,682 $6.8 p/Share	1,718 Added 25.53%	5,012 Common Stock
Aug 07 2023	SELL Open market or private sale	$271,372 $24.18 p/Share	11,223 Reduced 77.31%	3,294 Common Stock
Aug 07 2023	BUY Exercise of conversion of derivative security	$58,418 $6.8 p/Share	8,591 Added 37.18%	14,517 Common Stock

Jennifer Chien

EVP, Head of North America

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RYTM shares.

Notify only if

Value

Insider Trading

Get notified when an Rhythm Pharmaceuticals, Inc. insider buys or sells RYTM shares.

Notify only if

Operation

Value

Type

News

Receive news related to RHYTHM PHARMACEUTICALS, INC.

Track Activities on RYTM

Account